Amyotrophic Lateral Sclerosis

Drug Name: Qalsody Indications: To treat amyotrophic lateral sclerosis in adults who have a SOD1 gene mutation. Active Ingredient: Tofersen Company: Biogen MA Inc. Approval Date: 4/25/2023 More Details: https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215887s000lbl.pdf

Drug Name: Relyvrio Active Ingredient: sodium phenylbutyrate/taurursodiol Indications: To treat amyotrophic lateral sclerosis (ALS) Approval Date: 9/29/2022 Company: Amylyx Pharmaceuticals, Inc Learn more:  https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/216660s000lbledt.pdf